Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell death. by Guillaume Robert, Issam Ben Sahra, Alexandre Puissant, Pascal Colosetti, Nathalie Belhacene, Pierre Gounon, Paul Hofman, Fréderic Bost, Jill-Patrice Cassuto, Patrick Auberger

Get full text

Apoptosis And Genotoxicity Of Selected Β-Carboline Compounds Against Chronic Myelogenous Leukemia Using In Vitro Experimental Models by Kamaruzaman, Nur Azzalia

Get full text

Leukostasis retinopathy treated with Anti-VEGF therapy by Nasim Shakibai, Sai H. Chavala, MD

Subjects: “…Chronic myelogenous leukemia…”
Get full text

Leukemic retinopathy, a rare entity: A case report by Aman Kumar Gupta, Rakshya Basnet, Roshan Dev Yadav, Sweta Singh

Subjects: “…chronic myelogenous leukemia…”
Get full text

PHILADELPHIA CHROMOSOME by Habibullah Khan

Subjects: Get full text

Imatinib-Induced Psoriasis by Figen Atalay, Ebru Kızılkılıç, R. Simin Ada

Subjects: “…chronic myelogenous leukemia…”
Get full text

ALLOGENEIC PERIPHERAL BLOOD AND BONE MARROW STEM CELL TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA: A SINGLE CENTER STUDY by A. Ghavamzadeh, M. Iravani, M. Jahani, B. Bahar, A. Mousavi, S. Gholibeikian, M. Jafari F. Safavifar

Get full text

RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations by Hongxia Zhang, Yueya Zhong, Yuanming He, Yujia Xu, Ying Ren, Haixia Zhuang, Tong Sun, Zhigang Zhu, Xinliang Mao

Get full text

Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment by Okumura LM, Antunes VD, Aguiar KS, Farias T, Andrzejevski VM, Funke VM

Get full text

<i>Trifolium Repens</i> Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway by Federica Sarno, Giacomo Pepe, Pasquale Termolino, Vincenzo Carafa, Crescenzo Massaro, Fabrizio Merciai, Pietro Campiglia, Angela Nebbioso, Lucia Altucci

Subjects: Get full text

A novel case of chronic spontaneous urticaria associated chronic myelogenous leukemia with rapid resolution upon treatment with imatinib by Alexis Tracy, MD, Julia Kahn, MS, Bob Geng, MD, Marian Russo, MD, Bijan Safai, MD

Subjects: Get full text

Prostate cancer, chronic myelogenous leukemia and multiple myeloma in a single patient: a case report and review of the literature by Abolghasem Allahyari, Amirhosein Maharati, Amir Masoud Jafari-Nozad, Alireza zangooie

Subjects: Get full text

The case of successful therapy with Nilotinib in patients with Ph-positive chronic myelogenous leukemia of chronic phase resistant to Interferon and Gleevec by N. A. Afanasyeva, G. A. Gusarova

Get full text

Inhibition of casein kinase 2 induces cell death in tyrosine kinase inhibitor resistant chronic myelogenous leukemia cells. by Ondřej Mitrovský, Denisa Myslivcová, Tereza Macháčková-Lopotová, Adam Obr, Kamila Čermáková, Šárka Ransdorfová, Jana Březinová, Hana Klamová, Markéta Žáčková

“…Chronic myelogenous leukemia (CML) is a myeloproliferative disease characterized by the BCR-ABL oncogene. …”
Get full text

CHARACTERISTIC OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AT THE POLYCLINIC OF ONCOLOGY, DR. SOETOMO GENERAL ACADEMIC HOSPITAL, SURABAYA, INDONESIA IN 2017 by M. Rifqi Wiyono, Siprianus Ugroseno Yudho Bintoro, Yetti Hernaningsi

Subjects: Get full text

Oroxyloside A Overcomes Bone Marrow Microenvironment-Mediated Chronic Myelogenous Leukemia Resistance to Imatinib via Suppressing Hedgehog Pathway by Xiaobo Zhang, Yicheng Liu, Lu Lu, Shaoliang Huang, Youxiang Ding, Yi Zhang, Qinglong Guo, Zhiyu Li, Li Zhao

Get full text

Anti-N-methyl-D-aspartate receptor encephalitis associated with chronic myelogenous leukemia, causality or coincidence? A case report by Ying Yu, Jun-Li Liu, Dai-Shi Tian

Subjects: Get full text

A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib by Sarah Tomassetti, Jennifer Lee, Xin Qing

Subjects: Get full text

Indole-3-carbinol induces apoptosis of chronic myelogenous leukemia cells through suppression of STAT5 and Akt signaling pathways by Majid Safa, Leila Jafari, Fatemeh Alikarami, Rima Manafi Shabestari, Ahmad Kazemi

Get full text

Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy. by Clemens Woywod, Franz X Gruber, Richard A Engh, Tor Flå

“…Targeted inhibition of the oncogenic BCR-ABL1 fusion protein using the ABL1 tyrosine kinase inhibitor imatinib has become standard therapy for chronic myelogenous leukemia (CML), with most patients reaching total and durable remission. …”
Get full text